21762-11-8

Upstream product

• 21762-10-7 (RS)-2-(3-nitrophenyl)propionic acid 
• 21520-26-3 (RS)-2-(4-chloro-3-nitrophenyl)-propionic acid 
• 938-95-4 2-(4-Chloro-phenyl)-propionic acid 
• 5400-78-2 1-(3-nitrophenyl)ethanol 
• 29067-55-8 (RS)-1-(1-bromoethyl)-3-nitrobenzene 
• 121-89-1 3-Nitroacetophenone 
• 21762-10-7 (R)-2-(3-nitro-phenyl)-propionic acid 

Downstream Products

• 103797-09-7 (+/-)-2-(3-acetylamino-phenyl)-propionic acid 
• 23279-50-7 2-[3-(Acetyl-ethyl-amino)-2,4,6-triiodo-phenyl]-propionic acid 
• 23217-79-0 2-[3-(Acetyl-methyl-amino)-2,4,6-triiodo-phenyl]-propionic acid 
• 23217-81-4 2-(3-Acetylamino-2,4,6-triiodo-phenyl)-propionic acid 
• 29067-70-7 2-(3-Butyrylamino-2,4,6-triiodo-phenyl)-propionic acid 
• 29220-07-3 2-(2,4,6-Triiodo-3-propionylamino-phenyl)-propionic acid 
• 21762-12-9 3-amino-2,4,6-triiodo-α-methyl-benzeneacetic acid 

Relevant academic research and scientific papers

Convenient syntheses of racemic 2-(3-nitrophenyl)propanoic acid and 2-(3-aminophenyl)propanoic acid

2-(4-Chlorophenyl)propanoic acid 1 is transformed to 2-(4-chloro-3-nitrophenyl)propanoic acid 2 (94% yield). Acid 2 can be converted to 2-(3-nitrophenyl)propanoic acid 3 (70% yield) or to 2-(3-aminophenyl)propanoic acid 4 (80% yield).

Anilionotropone derivatives

Anilinotropone derivatives represented by the following formula: STR1 wherein R is hydrogen or methyl and pharmaceutically acceptable salts thereof are disclosed. They exhibit anti-inflammatory and analgesic activity with low gastrointestinal action.